GSK Wants to Replace Drugs with Tiny Implants

“GlaxoSmithKline (GSK) has developed a division devoted entirely to bioelectronics that can be attached to nerves to regulate drugs, or even eliminate the need for them.  GSK is seen as a pioneer in this space, and is partially funding development of...